Teva Pharmaceutical Industries Limited
TEVA
주식 순위
#13226
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
주가
$41.51
마지막 동기화: 2026-10-16
시가총액
$483.77M
변동 (1일)
-0.85%
변동 (1년)
107.47%
국가
IL
거래 Teva Pharmaceutical Industries Limited (TEVA)
카테고리
Healthcare
의 시가총액 Teva Pharmaceutical Industries Limited(TEVA)
시가총액: $483.77M
October 2026 기준으로 Teva Pharmaceutical Industries Limited의 시가총액은 $483.77M입니다. 이는 당사 데이터에 따르면 Teva Pharmaceutical Industries Limited이 세계에서 13226th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2010부터 2026까지 Teva Pharmaceutical Industries Limited의 시가총액 기록
